These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9737816)

  • 21. Pharmacokinetics and pharmacodynamics of torasemide and furosemide in patients with diuretic resistant ascites.
    Gentilini P; La Villa G; Marra F; Carloni V; Melani L; Foschi M; Cotrozzi G; Quartini M; Chibbaro G; Tommasi AC; Bernareggi A; Simoni A; Buzzelli G; Laffi G
    J Hepatol; 1996 Oct; 25(4):481-90. PubMed ID: 8912147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic changes of diltiazem and desacetyldiltiazem after oral administration of diltiazem in rabbits with diabetes mellitus induced by alloxan.
    Choi JS; Kim YG
    Biopharm Drug Dispos; 2002 Apr; 23(3):115-20. PubMed ID: 12173546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of diclofenac in rat model of diabetes mellitus induced by alloxan or steptozotocin.
    Kim YC; Oh EY; Kim SH; Lee MG
    Biopharm Drug Dispos; 2006 Mar; 27(2):85-92. PubMed ID: 16312011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic and pharmacodynamic changes of azosemide after intravenous and oral administration of azosemide to uranyl nitrate-induced acute renal failure rats.
    Park KJ; Yoon WH; Kim SH; Shin WG; Lee MG
    Biopharm Drug Dispos; 1998 Apr; 19(3):141-6. PubMed ID: 9569995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circadian changes in the pharmacokinetics and pharmacodynamics of azosemide in rats.
    Han KS; Lee MG
    J Pharm Pharmacol; 1998 Jul; 50(7):767-74. PubMed ID: 9720626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of plasma protein binding on renal metabolism and dynamics of furosemide in the rabbit.
    Pichette V; Geadah D; du Souich P
    Drug Metab Dispos; 1999 Jan; 27(1):81-5. PubMed ID: 9884313
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of intravenous trasemide in mutant Nagase analbuminemic rats.
    Kim EJ; Lee MG
    Biopharm Drug Dispos; 2003 Jan; 24(1):27-35. PubMed ID: 12516076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic changes of oral sulfamethoxazole in rabbits with diabetes mellitus induced by alloxan.
    Choi JS; Choi BC
    Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):332-40. PubMed ID: 11958286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Furosemide as a functional marker of acute kidney injury in ICU patients: a new role for an old drug.
    Mariano F; Mella A; Vincenti M; Biancone L
    J Nephrol; 2019 Dec; 32(6):883-893. PubMed ID: 31090022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The changes in renal function after a single dose of intravenous furosemide in patients with compensated liver cirrhosis.
    Assy N; Kayal M; Mejirisky Y; Gorenberg M; Hussein O; Schlesinger S
    BMC Gastroenterol; 2006 Nov; 6():39. PubMed ID: 17134488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and diuretic effect of furosemide after single intravenous, oral tablet, and newly developed oral disintegrating film administration in healthy beagle dogs.
    Koh SK; Jeong JW; Choi SI; Kim RM; Koo TS; Cho KH; Seo KW
    BMC Vet Res; 2021 Sep; 17(1):295. PubMed ID: 34488750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of water deprivation for 72 hours on the pharmacokinetics of DA-7867, a new oxazolidinone, in rats.
    Bae SK; Kim YC; Lee JK; Kwon JW; Yoo M; Lee I; Lee MG
    Biopharm Drug Dispos; 2006 Apr; 27(3):147-56. PubMed ID: 16408258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Renal pharmacodynamic effects of torasemide and furosemide in normal man.
    Dupont AG; Gerlo E; Van der Niepen P; Laekeman G; Piepsz A
    Arzneimittelforschung; 1988 Jan; 38(1A):172-5. PubMed ID: 3285829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diuretic effect and disposition of furosemide in cystic fibrosis.
    Prandota J; Smith IJ; Hilman BC; Wilson JT
    Eur J Clin Pharmacol; 1991; 40(4):333-41. PubMed ID: 2050167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized, open-label, 5-way crossover study to evaluate the pharmacokinetic/pharmacodynamic interaction between furosemide and the non-steroidal anti-inflammatory drugs diclofenac and ibuprofen in healthy volunteers.
    Paterson CA; Jacobs D; Rasmussen S; Youngberg SP; McGuinness N
    Int J Clin Pharmacol Ther; 2011 Aug; 49(8):477-90. PubMed ID: 21781648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender differences in pharmacokinetics and pharmacodynamics of azosemide in rats.
    Lee YS; Han KS; Lee MG
    Biopharm Drug Dispos; 1999 May; 20(4):225-9. PubMed ID: 10440798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of losartan and its metabolite, EXP3174, after intravenous and oral administration of losartan to rats with streptozotocin-induced diabetes mellitus.
    Moon CH; Lee HJ; Jung YS; Lee SH; Baik EJ
    Res Commun Mol Pathol Pharmacol; 1998 Aug; 101(2):147-58. PubMed ID: 9821211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacology of furosemide in children: a supplement.
    Prandota J
    Am J Ther; 2001; 8(4):275-89. PubMed ID: 11441327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of moderate hypoalbuminaemia on the renal metabolism and dynamics of furosemide in the rabbit.
    Pichette V; Geadah D; du Souich P
    Br J Pharmacol; 1996 Nov; 119(5):885-90. PubMed ID: 8922736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of ascorbic acid enhancement of the bioavailability and diuretic effect of furosemide.
    Lee MG; Chiou WL
    Drug Metab Dispos; 1998 May; 26(5):401-7. PubMed ID: 9571221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.